BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Obesity and Drug Dosing: Clinical Pharmacology Consideration
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-08521-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:FDA comments close: Obesity and Drug Dosing: Clinical Pharmacology
  Considerations\; Request for Comments
DESCRIPTION:Notice. Federal Register 2026-08521. Docket FDA-2026-N-3499. D
 etails: https://docket-clock.pages.dev/doc/2026-08521/ Official: https://
 www.federalregister.gov/documents/2026/05/01/2026-08521/obesity-and-drug-
 dosing-clinical-pharmacology-considerations-request-for-comments
URL:https://www.federalregister.gov/documents/2026/05/01/2026-08521/obesit
 y-and-drug-dosing-clinical-pharmacology-considerations-request-for-commen
 ts
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR